Table 1. Subject Characteristics.
Varenicline (N=18) | Placebo (N=20) | p-Value | |
---|---|---|---|
Age (years), mean±SD | 22.4±4.33 | 22.7±2.98 | 0.864 |
Sex, % female | 55.6 | 50.0 | 0.732 |
Occupation, % | 0.485 | ||
(PhD)-student | 88.9 | 95.0 | |
Other | 11.1 | 5.0 | |
Body weight (kg), mean±SD | 66.29±10.46 | 66.68±6.92 | 0.894 |
Body mass index, mean±SD | 22.8±2.33 | 22.6±1.96 | 0.782 |
BDI baseline, mean±SD | 2.00±3.53 | 1.80±2.10 | 0.833 |
BDI endpoint, mean±SD | 2.17±3.81 | 2.30±3.26 | 0.909 |
Abbreviation: BDI, Beck depression inventory.